Related Experiment Videos
PAX6 methylation and ectopic expression in human tumor cells
C E Salem1, I D Markl, C M Bender
1Urologic Cancer Research Laboratory, USC/Norris Comprehensive Cancer Center, University of Southern California, School of Medicine, Los Angeles, California 90089, USA.
International Journal of Cancer
|June 22, 2000
Summary
CpG island methylation in cancer is poorly understood. This study found that hypermethylation in exon 5 of the PAX6 gene occurs frequently in colon and bladder cancers without blocking transcription, unlike promoter methylation which silences the gene.
Area of Science:
- Cancer Biology
- Epigenetics
- Molecular Oncology
Background:
- Mechanisms of de novo CpG island methylation in human cancers are largely unknown.
- Understanding epigenetic alterations is crucial for cancer research and therapy.
Purpose of the Study:
- To investigate novel patterns of DNA methylation in colon and bladder cancers.
- To identify specific genes and regulatory regions affected by aberrant methylation in tumors.
Main Methods:
- Utilized methylation-sensitive arbitrarily primed polymerase chain reaction (Ms AP-PCR) to screen for differential DNA methylation.
- Analyzed methylation patterns in exon 5 and promoter regions of the PAX6 gene in tumor and normal tissues.
- Assessed the impact of methylation on PAX6 gene expression and utilized 5-aza-2'-deoxycytidine treatment to evaluate promoter methylation effects.
Main Results:
- Identified a 550 bp CpG-rich region in exon 5 of the PAX6 gene that was frequently hypermethylated (63% in bladder and colon tumors).
- Found that hypermethylation of PAX6 exon 5 did not inhibit gene transcription, as evidenced by ectopic PAX6 expression in tumors.
- Observed de novo promoter methylation exclusively in tumor cell lines, which was associated with gene silencing and reversed by 5-aza-2'-deoxycytidine treatment.
Conclusions:
- Hypermethylation within transcribed regions, such as PAX6 exon 5, does not necessarily block gene expression.
- Promoter methylation, in contrast, is linked to gene silencing in cancer.
- These findings highlight distinct roles of methylation in different genomic contexts within cancer development.